This startup is developing biomedicines that target the underlying mechanisms of Rheumatoid Arthritis and other autoimmune diseases through specific immunomodulatory therapies. By focusing on precise biological pathways, the company aims to provide effective treatment options that improve patient outcomes and quality of life.
Funding
Funding not disclosed
Founders
Product
Problem
Rheumatoid Arthritis (RA) and other autoimmune diseases lack curative therapies, with current treatments primarily managing symptoms rather than addressing the underlying causes. Existing therapies often have limited efficacy and can be associated with significant side effects, leading to a need for more targeted and effective treatment options. The multifactorial nature of RA, with unknown triggering antigens, complicates the development of disease-modifying treatments.
Solution
Arthritis4Cure is developing targeted, curative biomedicines designed to address the root causes of Rheumatoid Arthritis and other autoimmune diseases. The company's approach involves a precision medicine strategy, utilizing targeted cell therapies to modulate the immune system and restore balance. By focusing on specific biological pathways implicated in autoimmune disease, Arthritis4Cure aims to develop therapies that offer improved efficacy and reduced side effects compared to existing treatments. The company is developing a platform of novel biomolecules with the goal of achieving a technological breakthrough in the treatment of RA and other autoimmune conditions. The project aims to integrate within the IMMUN4CURE Institute, a European center including clinical, R&D, and bioproduction facilities.
Target Audience
The primary target audience includes patients suffering from Rheumatoid Arthritis and other autoimmune diseases, as well as rheumatologists and other healthcare providers seeking more effective and curative treatment options.
Features
- Development of targeted cell therapies for Rheumatoid Arthritis and other autoimmune diseases.
- Focus on immunomodulation to address the underlying mechanisms of autoimmune disorders.
- Preclinical R&D and drug design unit.
- Integration within the IMMUN4CURE Institute, facilitating clinical translation and bioproduction.
- Pipeline of translational research projects.